High Prevalence of Undiagnosed Impaired Glucose Regulation and Diabetes Mellitus in Patients Scheduled for an Elective Coronary Angiography

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2006 Apr 7

PMID 16598515

Citations 12

Authors

M Lankisch

R Futh

D Schotes

B Rose

H Lapp

W Rathmann

B Haastert

H Gulker

W A Scherbaum

Stephan Martin

Affiliations

Soon will be listed here.

Abstract

Background: Impaired glucose regulation (IGR) and diabetes mellitus (DM) are amongst the main risk factors for developing coronary heart disease (CHD). The aim of this study was to investigate previously unknown glucose metabolism disorder in patients scheduled for an elective coronary angiography.

Methods: A total of 141 patients scheduled for coronary angiography without signs of acute myocardial ischemia or previous history of a glucose metabolism disorder were prospectively included in the study. An oral glucose tolerance test (OGTT) was performed in each patient.

Results: IGR was diagnosed in 40.4% (95% confidence interval 32.3-49.0) and undetected DM in 22.7% (16.1-30.5) of patients undergoing an elective coronary angiography. Depending on the severity of CHD, the percentage of IGR and DM increased up to 45.3% (34.6-56.5) and 26.7% (17.8-37.4) in the subgroup with the need of percutaneous angioplasty, while the corresponding proportions in the group without CHD were 30.3% (15.6-48.7) and 12.1% (3.4-28.2). The percentage of undiagnosed DM increased with the number of epicardial vessels involved. Using the recommended fasting plasma glucose value of > or = 126 mg/dl for the diagnosis of DM, we would have missed 71.9% of the patients with undiagnosed DM. If all patients with a fasting plasma glucose of > or = 90 mg/dl had been subjected to OGTT, 93.8% of DM would have been identified.

Conclusions: Prevalences of DM and IGR are higher than expected in patients with CHD. An OGTT should be considered for all patients with a fasting plasma glucose > or = 90 mg/dl undergoing a coronary angiography.

Citing Articles

Recognition of incident diabetes mellitus during an acute myocardial infarction.

Arnold S, Stolker J, Lipska K, Jones P, Spertus J, McGuire D Circ Cardiovasc Qual Outcomes. 2015; 8(3):260-7.

PMID: 25901045 PMC: 4439264. DOI: 10.1161/CIRCOUTCOMES.114.001452.

Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.

Balakrishnan R, Berger J, Tully L, Vani A, Shah B, Burdowski J Diabetes Metab Res Rev. 2015; 31(6):603-9.

PMID: 25728823 PMC: 4694566. DOI: 10.1002/dmrr.2646.

The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction.

Arnold S, Lipska K, Inzucchi S, Li Y, Jones P, McGuire D BMJ Open Diabetes Res Care. 2014; 2(1):e000046.

PMID: 25452878 PMC: 4242083. DOI: 10.1136/bmjdrc-2014-000046.

Clinical benefit and improvement of activity level after reconstruction surgery of Charcot feet using external fixation: 24-months results of 292 feet.

Illgner U, Budny T, Frohne I, Osada N, Siewe J, Wetz H BMC Musculoskelet Disord. 2014; 15:392.

PMID: 25417055 PMC: 4289265. DOI: 10.1186/1471-2474-15-392.

Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.

Kuramitsu S, Yokoi H, Domei T, Nomura A, Watanabe H, Yamaji K Cardiovasc Diabetol. 2013; 12:74.

PMID: 23651930 PMC: 3651729. DOI: 10.1186/1475-2840-12-74.

References

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001; 161(3):397-405. DOI: 10.1001/archinte.161.3.397. View

Malmberg K, Norhammar A, Wedel H, Ryden L . Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial.... Circulation. 1999; 99(20):2626-32. DOI: 10.1161/01.cir.99.20.2626. View

Chiasson J, Josse R, Gomis R, Hanefeld M, Karasik A, Laakso M . Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359(9323):2072-7. DOI: 10.1016/S0140-6736(02)08905-5. View

Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. DOI: 10.1056/NEJM199807233390404. View

Mannebach H, Hamm C, Horstkotte D . [Not Available]. Z Kardiol. 2014; 91(9):727-9. DOI: 10.1007/s00392-002-0866-3. View

Van Belle E, Bauters C, Hubert E, Bodart J, Abolmaali K, Meurice T . Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation. 1997; 96(5):1454-60. DOI: 10.1161/01.cir.96.5.1454. View

. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):854-65. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

10.

Holmes Jr D, Leon M, Moses J, Popma J, Cutlip D, Fitzgerald P . Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004; 109(5):634-40. DOI: 10.1161/01.CIR.0000112572.57794.22. View

11.

Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L . Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002; 359(9324):2140-4. DOI: 10.1016/S0140-6736(02)09089-X. View

12.

Hu F, Stampfer M, Haffner S, Solomon C, Willett W, Manson J . Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002; 25(7):1129-34. DOI: 10.2337/diacare.25.7.1129. View

13.

Carson J, Scholz P, Chen A, Peterson E, Gold J, Schneider S . Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002; 40(3):418-23. DOI: 10.1016/s0735-1097(02)01969-1. View

14.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

15.

Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L . Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J. 2003; 24(9):838-44. DOI: 10.1016/s0195-668x(02)00828-x. View

16.

de Lorgeril M, Salen P, Martin J, Monjaud I, Delaye J, Mamelle N . Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999; 99(6):779-85. DOI: 10.1161/01.cir.99.6.779. View

17.

. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

18.

Stone G, Ellis S, Cox D, Hermiller J, OShaughnessy C, Mann J . One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004; 109(16):1942-7. DOI: 10.1161/01.CIR.0000127110.49192.72. View

19.

Saydah S, Fradkin J, Cowie C . Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291(3):335-42. DOI: 10.1001/jama.291.3.335. View

20.

Kleiman N, Lincoff A, Kereiakes D, Miller D, Aguirre F, Anderson K . Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Circulation. 1998; 97(19):1912-20. DOI: 10.1161/01.cir.97.19.1912. View